Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep
NCT05458609Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lemborexant in alcohol use disorder (AUD), Insomnia, sponsored by Baylor College of Medicine. Started Feb 2023; status: completed.
02
Drugs
lemborexant
03
Conditions
alcohol use disorder (AUD)Insomnia
Beyond the preview
Go deeper on NCT05458609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458609.